Stent Specifically Designed to Prevent Restenosis

June 30, 2006

Using a closed-cell design, the CYPHER stent delivers sirolimus, a drug that selectively targets and interrupts proliferating cells early in the cell cycle, halting the development of neointimal hyperplasia while allowing natural healing and normal re-endothelialization. It is available in over-the-wire and rapid exchange delivery systems. It comes in 8, 13, 18, 28 and 30 mm lengths and has radio-opaque markers.

Your name: *

E-mail: *

The content of this field is kept private and will not be shown publicly.

Homepage:

Subject:

Comment: *

Input format

Filtered HTML

Web page addresses and e-mail addresses turn into links automatically.
Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd><p><br>

Full HTML

Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

More information about formatting options

By submitting this form, you accept the Mollom privacy policy.

May 21, 2013 — Unavoidable damage caused to the heart and lungs by radiotherapy treatment of tumors in the chest region can...

Zoll Receives Japanese Approval to Market Intravascular Temperature Management Technology

May 21, 2013 — Zoll Medical Corporation has received Shonin approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) to enter the Japanese market with its Intravascular Temperature...

Inpatients Who Have STEMI Heart Attacks More Likely to Die Than Outpatients

May 20, 2013 — If someone suffers a heart attack while walking down the street and is taken to the hospital quickly, his/her chances of survival are very good. But if someone has a heart attack...

View all

Common Drug Can Limit Radiation Damage to Cancer Patient’s Heart, Lungs

May 21, 2013 — Unavoidable damage caused to the heart and lungs by radiotherapy treatment of tumors in the chest region can...

Endovascular Repair Of Ruptured Aneurysms Saves More Lives Than Surgery

May 20, 2013 — Patients with ruptured...

University of Maryland Medical Center Launches Genetic-Testing Program For Cardiac Stent Patients

May 17, 2013 — Patients with coronary artery disease who undergo treatment at the University of Maryland Medical Center (UMMC) now can receive long-term therapy based on information found in their...

View all

Stent Specifically Designed to Prevent Restenosis

Related News

Related Articles